Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Boyd

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|August 2, 2003
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinomaMary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, et al.
Molecular Cancer Research : MCR|January 22, 2017
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT GenesEric A Ariazi, John C Taylor, Michael A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studiesKristin K Zorn, Amir A Jazaeri, Christopher S Awtrey, et al.
Cancer|March 23, 2011
A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagusDavid H Ilson, David Kelsen, Manish Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2004
Gene expression signature with independent prognostic significance in epithelial ovarian cancerDimitrios Spentzos, Douglas A Levine, Marco F Ramoni, et al.
Resuscitation|August 11, 2007
The impact of avalanche rescue devices on survivalHermann Brugger, Hans Jürg Etter, Benjamin Zweifel, et al.
Nature|February 12, 2008
Resistance to therapy caused by intragenic deletion in BRCA2Stacey L Edwards, Rachel Brough, Christopher J Lord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriersLauren Scheuer, Noah Kauff, Mark Robson, et al.
Cancer|January 28, 2003
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up dataJohn R Goffin, Pierre O Chappuis, Louis R Bégin, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|August 2, 2003
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinomaMary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, et al.
Molecular Cancer Research : MCR|January 22, 2017
A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT GenesEric A Ariazi, John C Taylor, Michael A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studiesKristin K Zorn, Amir A Jazaeri, Christopher S Awtrey, et al.
Cancer|March 23, 2011
A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagusDavid H Ilson, David Kelsen, Manish Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2004
Gene expression signature with independent prognostic significance in epithelial ovarian cancerDimitrios Spentzos, Douglas A Levine, Marco F Ramoni, et al.
Resuscitation|August 11, 2007
The impact of avalanche rescue devices on survivalHermann Brugger, Hans Jürg Etter, Benjamin Zweifel, et al.
Nature|February 12, 2008
Resistance to therapy caused by intragenic deletion in BRCA2Stacey L Edwards, Rachel Brough, Christopher J Lord, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriersLauren Scheuer, Noah Kauff, Mark Robson, et al.
Cancer|January 28, 2003
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up dataJohn R Goffin, Pierre O Chappuis, Louis R Bégin, et al.
Pageof 9